Identification of Leishmania major and Other Causative Species in Syrian Patients Infected with Cutaneous Leishmaniasis
Abstract
Background: Leishmaniasis presents in three main clinical forms: Cutaneous (CL), Visceral (VL), and Mucocutaneous (MCL). In Hatay, CL is generally caused by L. infantum and L. tropica, with L. major appearing less frequently. Following the 2011 migration wave from Syria, we aimed to identify the causative Leishmania species, particularly L. major, among Syrian patients living in households and tent cities in Hatay, Turkey.
Methods: Smear preparations from 250 Syrian patients diagnosed with CL at Hatay Mustafa Kemal University, Turkey between 2011 and 2019 were retrospectively analyzed. DNA was isolated from these preparations, and molecular typing was performed by Real-Time Polymerase Chain Reaction (RT-PCR) using primers and probes specific to the ITS1 gene region.
Results: Molecular analysis revealed that 182 (72.8%) of 250 Syrian patients were infected with L. tropica, 59 (23.6%) with L. infantum/donovani, and 9 (3.6%) with L. major. While L. tropica and L. major are known causative species in Syria, the detection of L. infantum cases suggests the possibility of local transmission by sand flies, the primary vector in the Hatay region, during the patients' stay in tent cities.
Conclusion: The findings highlight the distribution of different Leishmania species among the Syrian population in Hatay. Implementing species-specific treatment protocols and maintaining effective notification and control activities are crucial for preventing the further spread of Cutaneous Leishmaniasis in the region.
2. World Health Organization. Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Wkly Epidemiol Rec. 2016;91(22):287–296.
3. Ministry of Health of the Republic of Türkiye, General Directorate of Public Health. Zoonotic Diseases – Documents [Internet]. Ankara: Ministry of Health of the Republic of Türkiye; [cited 2025 Jun 13]. Available from: https://hsgm.saglik.gov.tr/depo/birimler/zoonotik-ve-vektorel-hastaliklar-db/Dokumanlar/Istatistikler/Sark_Cibani_Istatistik.jpg
4. Gurel MS, Yesilova Y, Olgen MK, Ozbel Y. Cutaneous leishmaniasis in Turkey. Turkiye Parazitol Derg. 2012;36(2):121–129.
5. Rehman K, Walochnik J, Mischlinger J, Alassil B, Allan R, Ramharter M. Leishmaniasis in northern Syria during civil war. Emerg Infect Dis. 2018;24(11):1973–1981.
6. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354(2):119–130.
7. United Nations High Commissioner for Refugees. Syria situation [Internet]. Geneva: UNHCR; 2025. Available from: https://data.unhcr.org/en/situations/syria
8. Abbara A, Gonzalez-Sanz M, AlKharrat A, et al. Leishmaniasis in Syria: a call for action. Travel Med Infect Dis. 2025;66:102849.
9. Tayeh A, Jalouk L, Cairncross S. Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Trans R Soc Trop Med Hyg. 1997;91(6):657–659.
10. Youssef A, Harfouch R, El Zein S, Alshehabi Z, Shaaban R, Kanj SS. Visceral and cutaneous leishmaniases in a city in Syria and the effects of the Syrian conflict. Am J Trop Med Hyg. 2019;101(1):108–113.
11. Al-Salem WS, Pigott DM, Subramaniam K, et al. Cutaneous leishmaniasis and conflict in Syria. Emerg Infect Dis. 2016;22(5):931–933.
12. Culha G, Kaya T, Dogramaci AC. Genotyping of cutaneous leishmaniasis cases detected before and after migration with real-time polymerase chain reaction in Hatay. Turkiye Parazitol Derg. 2020; 44(1):48-51.
13. Toz SO, Nasereddin A, Ozbel Y, et al. Leishmaniasis in Turkey: molecular characterization of Leishmania from human and canine clinical samples. Trop Med Int Health. 2009;14(11):1401–1406.
14. Culha G, Akyar I, Zeyrek FY, et al. Leishmaniasis in Turkey: determination of Leishmania species by MALDI-TOF MS. Iran J Parasitol. 2014;9(2):239–248.
15. Ozbilgin A, Culha G, Uzun S, et al. First clinical isolation of Leishmania major in Turkey. Trop Med Int Health. 2016;21(6):783–791.
16. Korkmaz H, Cetin B, Ozsahin UE, Karatas A, Bom A. Geography of Hatay. In: Hatay Researches I. Antakya: Antakya Municipality Publications; 2010. p. 20–39.
17. Hatay Governorate. Social and geographical status of Hatay [Internet]. Hatay: Hatay Governorate; 2025 [cited 2025 Jun 15]. Available from: http://www.hatay.gov.tr/sosyal-ve-cografi-durum
18. Koc M, Gorucu I, Akbiyik N. Syrian refugees and employment problems. Individ Soc Sci J. 2015;5(1):63–94.
19. Karabork S, Celik H. The increasing incidence of type 1 diabetes from the perspective of climate change and new viral diseases. In: Full Text Book. p. 136–141.
20. Harman M. Cutaneous leishmaniasis. Turk J Dermatol. 2015;9(4):196–199.
21. Blackwell JM, Fakiola M, Castellucci LC. Human genetics of Leishmania infections. Hum Genet. 2020;139(6-9):813–819.
22. Uzun S, Gurel M, Harman M. Cutaneous leishmaniasis diagnosis and treatment guideline. Turkish Dermatology Association; 2017 Jun.
23. Delioglu M, Kalayci I. A qualitative research on migration and immigration from the perspective of Syrian Turks who migrated to Antakya. Anasay. 2022;(20):239–270.
24. Culha G, Akcali C. Detection of cutaneous leishmaniasis cases in Hatay and surrounding areas. Turkiye Parazitol Derg. 2006;30(4):268–271.
25. Culha G, Dogramaci AC, Kaya T, Cavus I, Gulkan B, Ozbilgin A. Imported cutaneous leishmaniasis cases detected in truck drivers in Hatay. Mikrobiyol Bul. 2018;52(3):316–323.
26. Yentur Doni N, Gurses G, Dikme R, et al. Cutaneous leishmaniasis among Syrian refugees in Sanliurfa. Acta Parasitol. 2020;65:936–948.
27. Zeyrek FY, Gurses G, Uluca N, et al. First cases of Leishmania major in Sanliurfa. Turkiye Parazitol Derg. 2014;38(4):270–274.
28. Baghad B, Razanapinaritra R, Maksouri H, et al. Possible introduction of Leishmania tropica to urban areas. Parasite Epidemiol Control. 2020;9:e00129.
29. Ozkeklikci A, Karakus M, Ozbel Y, Toz S. New situation of cutaneous leishmaniasis after Syrian civil war in Gaziantep. Acta Trop. 2017;166:35–38.
30. Ozbilgin A, Cavus I, Yildirim A, Kaya T, Ertabaklar H. Evaluation of in vitro and in vivo drug efficacy on Leishmania tropica. Turkiye Parazitol Derg. 2018;42(1):11–19.
31. Planerium. Male body outline [Internet]. 2022 [cited 2025 Jun 10]. Available from: https://www.planerium.com/wp-content/uploads/2022/11/male-body-outline-planerium.jpg
32. Mohammadiha A, Dalimi AH, Mohebali M, et al. Molecular identification and phylogenetic classification of Leishmania spp. Iran J Parasitol. 2018;13(3):351–361.
33. Mancy A, Awad KM, Abd-Al-Majeed T, Jameel NF. Epidemiology of cutaneous leishmaniasis in Al-Ramadi, Iraq. Our Dermatol Online. 2022;13(4):402–407.
| Files | ||
| Issue | Vol 21 No 1 (2026) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijpa.v21i1.21637 | |
| Keywords | ||
| Cutaneous leishmaniasis Leishmania spp. Polymerase chain reaction Genotype Turkey | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |

